Doctor Par Paren
Sahlgrenska University Hospital, Gothenburg (Sweden)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Trends in diuretic treatment between 2005 and 2011 in patients with heart failure
Event: ESC Congress 2017
Topic: Pharmacologic therapy
Session: Chronic heart failure (CHF)
Risk of long-term mortality associated with diuretic treatment in 17,519 heart failure outpatients was increased with 42% after adjustment for MAGGIC mortality risk predictors
Event: ESC Congress 2016
Topic: Pharmacologic therapy
Session: Drug therapy in heart failure
Adherence to international guidelines on diuretic treatment in heart failure based on congestive signs in 43,744 patients from SwedeHF
Event: ESC Congress 2016
Topic: Pharmacologic therapy
Session: Pharmacologic approaches in HF: could we do better?
ESC 365 is supported by
